Immune Globulin
Links shared publicly online about this topic
ingentaconnect Immune globulin: Headache, arthralgia and rhinoconjunctivitis: 5 ...
ingentaconnect.com — “ingentaconnect Immune globulin: Headache, arthralgia and rhinoconjunctivitis: 5 ...” View full resource at ingentaconnect.com
Most Recently Shared on April 25, 2011 at 6:25 am By:
Immune globulin: Headache, arthralgia and rhinoconjunctivitis: 5 case reports: (Source: Reactions) http://bit.ly/gZASPv
GAMMAGARD LIQUID (Immune globulin) drug information from MPR
empr.com — “GAMMAGARD LIQUID (Immune globulin) drug information for Immunodeficiency from MPR including side effects, drug interactions, dosing, contraindications and precautions.” View full resource at empr.com
Most Recently Shared on August 17, 2010 at 4:49 am By:
MPR News: GAMMAGARD LIQUID: Monograph added. http://bit.ly/cjMb3D
FDA Alert: GammaGard Liquid, Immune Globulin Intravenous (Human)
drugs.com — “FDA Alert: GammaGard Liquid, Immune Globulin Intravenous (Human)” View full resource at drugs.com
Most Recently Shared on June 8, 2010 at 11:05 pm By:
FDA Alert - Market Withdrawal: GammaGard Liquid - http://bit.ly/aIIVtb
Allergy Notes: Intravenous immune globulin (IVIG) in autoimmune and inflammatory disorders: how does it work?
allergynotes.blogspot.com — “Allergy and Asthma News Updated Daily by an Allergist and Assistant Professor at University of Chicago” View full resource at allergynotes.blogspot.com
Most Recently Shared on April 7, 2011 at 1:48 pm By:
Matthew Bowdish MD Physician, Doctor, Internist, and Allergist
Intravenous immune globulin (IVIG) in autoimmune and inflammatory disorders: how does it work? http://bit.ly/hRQ93v
Allergy Notes: Intravenous immune globulin (IVIG) in autoimmune and inflammatory disorders: how does it work?
allergynotes.blogspot.com — “Allergy and Asthma News Updated Daily by an Allergist and Assistant Professor at University of Chicago” View full resource at allergynotes.blogspot.com
Most Recently Shared on April 6, 2011 at 12:33 pm By:
allergydropz Surgeon, ENT Doctor, Physician, and Doctor
Allergy Notes: Intravenous immune globulin (IVIG) in autoimmune and inflammatory disorders: http://bit.ly/hwSjKV Full http://bit.ly/eNPGa3
FDA Alert: Octagam (Immune Globulin Intravenous (human)) 5% Liquid Preparation: Market Withdrawal - Risk of Thromboembolic Events
drugs.com — “FDA Alert: Octagam (Immune Globulin Intravenous (human)) 5% Liquid Preparation: Market Withdrawal - Risk of Thromboembolic Events” View full resource at drugs.com
Most Recently Shared on August 26, 2010 at 1:00 am By:
FDA Alert - Recall: Octagam (Immune Globulin Intravenous (human)) 5% Liquid Preparation - http://bit.ly/96F9Wz
FDA Alert: Octagam (Immune Globulin Intravenous (human)) 5% Liquid Preparation: Market Withdrawal - Risk of Thromboembolic Events
drugs.com — “FDA Alert: Octagam (Immune Globulin Intravenous (human)) 5% Liquid Preparation: Market Withdrawal - Risk of Thromboembolic Events” View full resource at drugs.com
Most Recently Shared on September 28, 2010 at 2:32 am By:
FDA Alert - Market Withdrawal: Octagam (Immune Globulin Intravenous (human)) - Risk of Thromboembolic Events - http://bit.ly/9P1vuY
Plasmapheresis and Intravenous Immune Globulin Improve Neurologic Outcome of Central Pontine Myelinolysis Occurring Post Orthotopic Liver Transplant -- Ludwig et al. 45 (2): e10 -- The Annals of Pharmacotherapy
theannals.com — “Plasmapheresis and Intravenous Immune Globulin Improve Neurologic Outcome of Central Pontine Myelinolysis Occurring Post Orthotopic Liver Transplant -- Ludwig et al. 45 (2): e10 -- The Annals of Pharmacotherapy” View full resource at theannals.com
Most Recently Shared on February 23, 2011 at 4:18 am By:
Plasmapheresis and Intravenous Immune Globulin Improve Neurologic Outcome of Central Pontine Myelinolysis Occurr... http://bit.ly/dXhiX1
Investigational Immune Intervention Slows Brain Shrinkage In Alzheimer's Patients
medicalnewstoday.com — “An investigational intervention using naturally ocurring antibodies in human blood has preserved the thinking abilities of a group of mild- to moderate-stage Alzheimer's patients over 18 months an” View full resource at medicalnewstoday.com
Most Recently Shared on April 14, 2010 at 3:29 pm By:
MNT Alzheimer's News Health News
Investigational Immune Intervention Slows Brain Shrinkage In Alzheimer's Patients http://mnt.to/3Bcr #alzheimers
Pediatrics Medical News about Purpura, Thrombocytopenic
mdlinx.com — “Comparison of intravenous immune globulin and high dose anti-D immune globulin as initial therapy for childhood immune thrombocytopenic purpura” View full resource at mdlinx.com
Most Recently Shared on January 25, 2010 at 10:10 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Peds: Comparison of intravenous immune globulin and high dose anti-D immune globulin as initial therapy for childhood i http://url4.eu/1DTrW
Interim data from HyQ Phase III clinical study in primary immune deficiency presented at 26th ESID
news-medical.net — “Data from interim analyses of a Phase III clinical study in patients with primary immune deficiency (PID) who received Baxter's HyQ were presented at the 26th meeting of the European Society for Immunodeficiencies (ESID) in Istanbul, Turkey. HyQ is an immune globulin (IG) therapy facilitated subcutaneously by recombinant human hyaluronidase, a dispersion and permeation enhancer.” View full resource at news-medical.net
Most Recently Shared on October 6, 2010 at 1:03 pm By:
Interim data from HyQ Phase III clinical study in primary immune deficiency presented at 26th ESID: Data from inte... http://bit.ly/b43kcS
Talecris Biotherapeutics Receives FDA Approval for Gamunex-C
drugs.com — “Gamunex-C (immune globulin subcutaneous (human)) is used to treat primary immunodeficiency. Includes Gamunex-C side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on October 17, 2010 at 11:49 pm By:
Talecris Biotherapeutics Receives FDA Approval for Gamunex-C - http://bit.ly/drm0FC
Medical News: Embolic Events Force IVIG Product Recall - in Product Alert, Prescriptions from MedPage Today
medpagetoday.com — “All lots of Octapharma USA's 5% liquid intravenous immune globulin product Octagam have been recalled because of an unexpected number of thromboembolic events seen after administration, the FDA announ” View full resource at medpagetoday.com
Most Recently Shared on September 25, 2010 at 1:24 am By:
Embolic Events Force IVIG Product Recall http://ow.ly/199tn9
CSL Behring Receives FDA Approval To Extend Shelf Life For Privigen(R) From 24 To 36 Months
medicalnewstoday.com — “CSL Behring announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) to extend the shelf life for Privigen®, Immune Globulin” View full resource at medicalnewstoday.com
Most Recently Shared on April 24, 2010 at 3:07 pm By:
CSL Behring Receives FDA Approval To Extend Shelf Life For Privigen(R) From 24 To 36 Months http://mnt.to/3BJf #biology
Talecris Biotherapeutics Receives FDA Approval For Gamunex®-C
medicalnewstoday.com — “Talecris Biotherapeutics (Nasdaq: TLCR) announced that the U.S. Food and Drug Administration (FDA) approved Gamunex®-C (Immune Globulin Injection [Human], 10% Caprylate/Chromatography Purifie” View full resource at medicalnewstoday.com
Most Recently Shared on October 15, 2010 at 4:05 pm By:
MNT Pharma News Health News and Pharma
Talecris Biotherapeutics Receives FDA Approval For Gamunex®-C http://mnt.to/3Lgv #pharma #pharmaceutical
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Migraine OW
Organizing migraine resources shared by health experts, advocates, and organizations into WisdomCards.
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
Advertisement
